Emerging technology program

21 U.S. Code § 360bbb-5a. Emerging technology program

(a) Program establishment
(1) In general
The Secretary shall establish a program to support the adoption of, and improve the development of, innovative approaches to drug design and manufacturing.
(2) ActionsIn carrying out the program under paragraph (1), the Secretary may—
(A)
facilitate and increase communication between public and private entities, consortia, and individuals with respect to innovative drug product design and manufacturing;
(B)
solicit information regarding, and conduct or support research on, innovative approaches to drug product design and manufacturing;
(C)
convene meetings with representatives of industry, academia, other Federal agencies, international agencies, and other interested persons, as appropriate;
(D)
convene working groups to support drug product design and manufacturing research and development;
(E)
support education and training for regulatory staff and scientists related to innovative approaches to drug product design and manufacturing;
(F)
advance regulatory science related to the development and review of innovative approaches to drug product design and manufacturing;
(G)
convene or participate in working groups to support the harmonization of international regulatory requirements related to innovative approaches to drug product design and manufacturing; and
(H)
award grants or contracts to carry out or support the program under paragraph (1).
This document is only available to subscribers. Please log in or purchase access.